Literature DB >> 3128459

Class-II and IL2 receptor positive cells in the pancreas of NOD mice.

A Signore1, A Cooke, P Pozzilli, G Butcher, E Simpson, P C Beverley.   

Abstract

The aberrant expression of Class-II molecules on pancreatic B cells in Type 1 (insulin-dependent) diabetes is still a matter of debate. In order to verify if Class-II molecules are expressed on islet cells in the NOD mouse we have studied 21 female mice of different ages (5 to 22 weeks). Serial cryostat pancreas sections were stained with monoclonal rat antibodies against Class-II antigens (P7/7) and the IL2 receptor (AMT-13). Our results show no Class-II expression by endocrine cells at any age, whereas about 25-32% of mononuclear cells infiltrating the islets were Class-II positive, and only 6-9% were IL2 receptor positive. No staining, except of occasional tissue macrophages, was observed in the pancreas of BALB/c, CBA or B10.SCSN mice. Our data are in contrast with those recently published and therefore the reality of expression of Class-II molecules by islet cells of NOD mice should be viewed with caution.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3128459     DOI: 10.1007/bf00274802

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  17 in total

1.  Separation of suppressor and killer T cells by surgace phenotype.

Authors:  P C Beverley; J Woody; M Dunkley; M Feldmann; I McKenzie
Journal:  Nature       Date:  1976-08-05       Impact factor: 49.962

2.  Expression of MHC class II and Tac antigens on IL2-activated human T cell clones that can stimulate in MLR, AMLR, PLT and can present antigen.

Authors:  F Triebel; S de Roquefeuil; C Blanc; D J Charron; P Debre
Journal:  Hum Immunol       Date:  1986-03       Impact factor: 2.850

3.  The spontaneously diabetic Wistar rat (the "BB" rat). Studies prior to and during development of the overt syndrome.

Authors:  A F Nakhooda; A A Like; C I Chappel; C N Wei; E B Marliss
Journal:  Diabetologia       Date:  1978-03       Impact factor: 10.122

4.  Pre-diabetes in the spontaneously diabetic BB/E rat: lymphocyte subpopulations in the pancreatic infiltrate and expression of rat MHC class II molecules in endocrine cells.

Authors:  B M Dean; R Walker; A J Bone; J D Baird; A Cooke
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

5.  Islet cell surface and lymphocyte antibodies often precede the spontaneous diabetes in the BB rat.

Authors:  T Dyrberg; P Poussier; F Nakhooda; E B Marliss; A Lernmark
Journal:  Diabetologia       Date:  1984-02       Impact factor: 10.122

6.  The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom.

Authors:  A K Foulis; C N Liddle; M A Farquharson; J A Richmond; R S Weir
Journal:  Diabetologia       Date:  1986-05       Impact factor: 10.122

7.  Expression of class II major histocompatibility complex antigens on pancreatic B cells in the NOD mouse.

Authors:  T Hanafusa; H Fujino-Kurihara; A Miyazaki; K Yamada; H Nakajima; J Miyagawa; N Kono; S Tarui
Journal:  Diabetologia       Date:  1987-02       Impact factor: 10.122

8.  Three recessive loci required for insulin-dependent diabetes in nonobese diabetic mice.

Authors:  M Prochazka; E H Leiter; D V Serreze; D L Coleman
Journal:  Science       Date:  1987-07-17       Impact factor: 47.728

9.  Recombinant interleukin 2 enhances spontaneous insulin-dependent diabetes in BB rats.

Authors:  H Kolb; J Zielasek; U Treichel; G Freytag; M Wrann; U Kiesel
Journal:  Eur J Immunol       Date:  1986-02       Impact factor: 5.532

10.  Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin-dependent) diabetes mellitus.

Authors:  A K Foulis; M A Farquharson; R Hardman
Journal:  Diabetologia       Date:  1987-05       Impact factor: 10.122

View more
  8 in total

Review 1.  MHC class II-associated variation in the production of tumor necrosis factor in mice and humans: relevance to the pathogenesis of autoimmune diseases.

Authors:  C O Jacob; G D Lewis; H O McDevitt
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1.

Authors:  C O Jacob; S Aiso; S A Michie; H O McDevitt; H Acha-Orbea
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

Review 3.  Temporal discontinuities in progression of NOD autoimmune diabetes.

Authors:  G B Rudy; R M Sutherland; A M Lew
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

4.  Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells.

Authors:  C Boitard; A Bendelac; M F Richard; C Carnaud; J F Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice.

Authors:  A Signore; P Pozzilli; E A Gale; D Andreani; P C Beverley
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

Review 6.  Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type 1 (insulin-dependent) diabetes mellitus.

Authors:  E F Lampeter; A Signore; E A Gale; P Pozzilli
Journal:  Diabetologia       Date:  1989-10       Impact factor: 10.122

7.  MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice.

Authors:  E H Leiter; G J Christianson; D V Serreze; A T Ting; S M Worthen
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

8.  AAV-mediated pancreatic overexpression of Igf1 counteracts progression to autoimmune diabetes in mice.

Authors:  Cristina Mallol; Estefania Casana; Veronica Jimenez; Alba Casellas; Virginia Haurigot; Claudia Jambrina; Victor Sacristan; Meritxell Morró; Judith Agudo; Laia Vilà; Fatima Bosch
Journal:  Mol Metab       Date:  2017-05-17       Impact factor: 7.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.